Pociredir Evidence: Trial Results and Peer-Reviewed Publications
Hipa.ai Research · Source: PubMed & ClinicalTrials.gov / AACT · Last updated:
The clinical evidence base for Pociredir comprises 6 peer-reviewed publications across 6 journals, 0 pivotal-trial primary-outcome rows reported to ClinicalTrials.gov, spanning indications including Anemia, Sickle Cell. Most recent publication: Management of Kidney Disease with Sickle Cell Disease., J Am Soc Nephrol, 2025.
Top peer-reviewed publications
Curated set of pivotal-trial result papers and recent publications in high-tier journals.
- Management of Kidney Disease with Sickle Cell Disease.Abbasi M, Srivastava A, Saraf SL, et al. · J Am Soc Nephrol · 2025
- Fetal hemoglobin in sickle cell anemia: a glass half full?Steinberg MH, Chui DH, Dover GJ, et al. · Blood · 2014
- Differences in the clinical and genotypic presentation of sickle cell disease around the world.Saraf SL, Molokie RE, Nouraie M, et al. · Paediatr Respir Rev · 2015
- The switch from fetal to adult hemoglobin.Sankaran VG, Orkin SH · Cold Spring Harb Perspect Med · 2013
- Sickle Cell Disease.Piel FB, Steinberg MH, Rees DC, et al. · N Engl J Med · 2017
- Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.Ngo DA, Aygun B, Akinsheye I, et al. · Br J Haematol · 2012
Publications by year
2012–2025: 6 publications.
2012
1
2013
1
2014
1
2015
1
2017
1
2025
1
Publications by indication
Anemia, Sickle Cell (6)
- Management of Kidney Disease with Sickle Cell Disease.
- Sickle Cell Disease.
- Differences in the clinical and genotypic presentation of sickle cell disease around the world.
- Fetal hemoglobin in sickle cell anemia: a glass half full?
- The switch from fetal to adult hemoglobin.
Publications by journal
- J Am Soc Nephrol1 paper
- Blood1 paper
- Paediatr Respir Rev1 paper
- Cold Spring Harb Perspect Med1 paper
- N Engl J Med1 paper
- Br J Haematol1 paper
All Pociredir publications (6)
2025 (1 paper)
- Management of Kidney Disease with Sickle Cell Disease.Abbasi M, Srivastava A, Saraf SL, et al. · J Am Soc Nephrol · 2025 · Derived
2017 (1 paper)
- Sickle Cell Disease.Piel FB, Steinberg MH, Rees DC, et al. · N Engl J Med · 2017 · Background
2015 (1 paper)
- Differences in the clinical and genotypic presentation of sickle cell disease around the world.Saraf SL, Molokie RE, Nouraie M, et al. · Paediatr Respir Rev · 2015 · Background
2014 (1 paper)
- Fetal hemoglobin in sickle cell anemia: a glass half full?Steinberg MH, Chui DH, Dover GJ, et al. · Blood · 2014 · Background
2013 (1 paper)
- The switch from fetal to adult hemoglobin.Sankaran VG, Orkin SH · Cold Spring Harb Perspect Med · 2013 · Background
2012 (1 paper)
- Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.Ngo DA, Aygun B, Akinsheye I, et al. · Br J Haematol · 2012 · Background
Sources and methodology
- Publications:
ctgov.study_references(PubMed PMIDs auto-attached by ClinicalTrials.gov to each trial), reference typesRESULT,DERIVED, andBACKGROUND. - Per-arm outcome values:
ctgov.outcome_measurementsjoined toctgov.design_outcomeswhereoutcome_type = 'PRIMARY', restricted to phasePHASE3andPHASE2/PHASE3. - Publication metadata (title, journal, year, authors): PubMed E-utilities
efetch.fcgi - Data freshness: Thu, 14 May 2026 22:27:03 GMT.
This page summarizes published evidence for general reference and does not constitute medical advice. For clinical decisions, consult the linked primary publications and your healthcare provider. Data sourced from PubMed and the ClinicalTrials.gov / AACT database maintained by the Clinical Trials Transformation Initiative (CTTI).